Company Email Format Management

Malcisbo Ltd.

Biotechnology Research Ch 5 employees

Employees: 5
Contacts: 2
Emails: 2

malcisbo.com LinkedIn Crunchbase

Malcisbo Ltd. Overview

Headquarters: Ch
Phone Number: Available in AeroLeads
Website: malcisbo.com
Industry: Biotechnology Research
Employees: 5
Funding: 94.8K
Company Email: Available in AeroLeads
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

About Malcisbo Ltd.

Sweet vaccines are novel carbohydrate based vaccines being developed by the company Malcisbo. The first targets are unmet medical needs such as Campylobacter induced food poisoning and parasitic infections by the blood sucking stomach worm Hemonchus in sheep causing losses in food production. Malcisbo has developed a proprietary target discovery platform which it will use in combination with glycoengineering technologies to provide novel and efficient glycoconjugate vaccines. The discovery platform will generate a constant outflow of novel vaccines for unmet human and veterinary medical needs. Further projects are affordable vaccines to protect people in underdeveloped areas against parasitic worm infections.

Malcisbo Ltd. Contact Details

People in AeroLeads: 3
With contact data: 2
Email contacts: 2; 66.7% coverage

Malcisbo Ltd. Org Chart

Sample employees and titles

Name	Title	Location	Contact
Chhunthangpuii Undefined			View
Benjamin Wilhelm	Global Head of Strategy & Partnerships	Greater Hamburg Area, Germany	Email
Lino Camponovo	CEO Trebeco Consulting Pvt. Ltd.	Zürich Metropolitan Area, Switzerland	Email